Enforcement record

承認 against 日本イーライリリー株式会社

日本イーライリリー株式会社 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)

This page is one enforcement record. Company-level Official Gazette notices, registry data, related-company signals, and other public records are collected on the company profile.

View company profile
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareConfirmed entity match23 April 2021

Action type

承認

Law

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices

Authority

Ministry of Health, Labour and Welfare

Action date

23 April 2021

Current page: Enforcement record

This screen focuses on one disclosed action: governing law, authority, facts, source status, and review evidence. Open the company profile for company-level registry, Official Gazette, and related-company context.

Free report

Save a public-record evidence report for 日本イーライリリー株式会社

Includes target-entity identifiers, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.

Related tool Kiroku

Track website changes for 日本イーライリリー株式会社

After checking public records, use Kiroku to save and monitor official websites, terms, IR pages, pricing pages, announcements, and other URLs that may change over time.

Open website change monitoring
For developers: JSON integration details

You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.

/api/v1/enforcements?corporate_number=3140001012176&limit=10

Action summary

Company
Original: 日本イーライリリー株式会社
Corporate Number: 3140001012176
Entity match
Confirmed entity match95/100Machine extracted
Normalized Japanese name matched to a company profile with Corporate Number
Matched by normalized Japanese company name to an enriched company profile with a Corporate Number.
Governing law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
医薬品医療機器等法
Action type
承認
承認
Action date
23 April 2021
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省
Industry context
医薬品

Violation

Machine-translated summary — verify against original

Indications and effects to be added: Pneumonia caused by SARS-CoV-2 (limited to patients requiring oxygen inhalation).

Show original Japanese text

追加する効能・効果:SARS-CoV-2による肺炎(ただし、酸素吸入を要する患者に限る)

Compliance context

Context needed

This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.

Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.

Review the original Japanese source and determine relevance to your counterparty-risk workflow.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Evidence pack

Original Ministry of Health, Labour and Welfare announcement (Japanese)Archived source snapshot
Extracted at
2026-04-25T00:17:36.717+00:00
Evidence checked
2026-04-25T00:17:36.717+00:00
Archive captured
2026-04-08T18:02:07.045+00:00
Show audit JSON
{
  "record": {
    "id": "5eb15186-a1fc-473c-9232-c4c35010ea6e",
    "url": "https://regbase.jp/en/enforcement/other-ri-ben-irairiri-20210423",
    "company_name_original": "日本イーライリリー株式会社",
    "company_name_registry": "日本イーライリリー株式会社",
    "corporate_number": "3140001012176",
    "law": {
      "ja": "医薬品医療機器等法",
      "en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
    },
    "action_type": {
      "ja": "承認",
      "en": "承認"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "confirmed",
    "confidence": 95,
    "method": "normalized_name_with_corporate_number",
    "method_label": "Normalized Japanese name matched to a company profile with Corporate Number",
    "notes": "Matched by normalized Japanese company name to an enriched company profile with a Corporate Number."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Context needed",
    "actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
    "practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
    "lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/other-ri-ben-irairiri-20210423",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_18199.html",
    "archiveUrl": "https://kiroku.today/view/6bcf071631qcv0mw",
    "archiveCapturedAt": "2026-04-08T18:02:07.045+00:00",
    "extractedAt": "2026-04-25T00:17:36.717+00:00",
    "translatedAt": "2026-05-01T07:06:40.25+00:00",
    "evidenceCheckedAt": "2026-04-25T00:17:36.717+00:00",
    "generatedAt": "2026-07-08T06:43:45.351Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.